|
Results of the endostatin Phase I (safety) clinical trials were released by the principal investigators leading the trials (see below) on Thursday, Nov. 9, at the European Organization for the Research and Treatment of Cancer (EORTC) meeting in Amsterdam. Dr. Judah Folkman gave a plenary address on Nov. 9 about lessons learned from the endostatin trials and through other experience with anti-angiogenesis therapy over the last several years.
Dr. Judah Folkman is not leading any of the Phase I endostatin clinical trials and Children's Hospital Boston is not a site for any of the Phase I endostatin clinical trials.
The trials are taking place at the following institutions. Please see their web sites for information about patient enrollment and/or for information about the results of their studies.
Instituto del Cáncer Dana-Farber
Boston, Massachusetts
617-632-5100
MD Anderson
Houston, Texas
800-392-1611
University of Wisconsin
Madison, Wisconsin
800-622-8922
Please also see the National Cancer Institute web site for further information on endostatin (http://cancertrials.nci.nih.gov/clinicaltrials).
National Cancer Institute
NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2580
Bethesda, Maryland 20892-2580
1-800-4-CANCER (1-800-422-6237)
(301) 435-3848
Information for patients outside the United States:
There are several ways to get information about possible treatment options available outside the United States. PDQ, the National Cancer Institute's cancer information database, contains information about clinical trials in Europe and elsewhere.
The International Union Against Cancer (UICC) consists of international cancer-related organizations devoted to the worldwide fight against cancer. UICC membership includes research facilities and treatment centers, and in some countries, ministries of health. Other members include volunteer cancer leagues, associations, and societies. These organizations serve as resources for the public and may have helpful information about cancer, treatment centers, and research studies. To find a resource in or near your country, contact the UICC at:
International Union Against Cancer
3, rue du Conseil General
1205 Geneva
Switzerland
Telephone: 41 22 809 18 11
E-mail: info@uicc.org
http://www.uicc.org
The European Organization for Research and Treatment of Cancer (EORTC) maintains information about clinical trials being conducted in European countries.
Please contact the EORTC at:
EORTC
Avenue Mounier, 83
B1200 Brussels
Belgium
Telephone: 32 (2) 774 16 11
Fax: 32 (2) 772 35 45
E-mail: eortc@eortc.be
http://www.eortc.be
|
